Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Da Huoluo Pill (also known as Da Huoluo Wan or Da Huoluo Dan) is a traditional Chinese medicine (TCM) formula developed and manufactured by Changshu Leiyunshang Pharmaceutical and other manufacturers. It is composed of dozens of herbal and animal-derived ingredients (typically 48 to 50 ingredients, including Qishe, Wushaoshe, Weilingxian, and others). Da Huoluo Pill is primarily indicated for the treatment of wind-cold-dampness arthralgia, numbness of limbs, muscle spasms, stroke-induced hemiplegia, paralysis, and traumatic injuries. It functions by dispelling wind, removing dampness, relaxing muscles, and activating collaterals to promote blood circulation and relieve pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Da Huoluo Pill.